Autologous Bone Marrow Aspirate Concentrate in Patients Undergoing Meniscectomy
Running, not enrolling · Not applicable · Has a placebo group
Conditions studied: Osteoarthritis Post-meniscectomy
In brief
The proposed research study aims to evaluate the effects of autologous bone marrow aspirate concentrate (BMAC) on the development and progression of osteoarthritis (OA) in patients undergoing meniscectomy. This prospective, randomized, double-blind clinical trial will compare patient-reported outcomes, specifically IKDC scores between patients who receive BMAC post-meniscectomy and those who receive a saline control injection. The study will also compare physical examination, MRI, radiographs, and synovial fluid analysis. Our hypothesis is that those who receive the autologous BMAC injection after the procedure will have better outcomes than those who do not.
Key facts
- Study ID
- NCT02582489
- Run by
- Rush University Medical Center
- People needed
- 100
- Starts
- 2017-12-22
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-04-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject is greater than 18 years old
- Written informed consent is obtained
- Subject is determined to have a symptomatic meniscal tear requiring a meniscectomy
- Meniscal pathology is confirmed through MRI and arthroscopically
- Subject agrees to all follow-up evaluations
- Osteoarthritis Kellen-Lawrence grade 1-3 on flexion PA and extension AP views
You may not qualify if…
- Any subject lacking decisional capability
- Unwillingness to participate in the necessary follow-up
- Subject is pregnant or may become pregnant
- History of diabetes mellitus
- History of rheumatoid arthritis or other autoimmune disorder
- History of solid organ or hematologic transplantation
- Diagnosis of a non-basal cell malignancy within the preceding 5 years
- Infection requiring antibiotic treatment within the preceding 3 months
- Osteoarthritis Kellen-Lawrence grade 4 on flexion posterior-anterior (PA) or extension anteroposterior (AP) views
- Prior surgery on the index meniscus
- Concomitant surgery such as ligament surgery or cartilage repair or restoration
- Infection
- Prior cortisone/viscosupplementation/ (platelet rich plasma) PRP injection within 6 weeks
Where it is running
- Rush University Medical Center — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.